MacroGenics, Inc. (MGNX) vs Zentalis Pharmaceuticals, Inc. (ZNTL)
- MacroGenics, Inc. MGNX 3.25 −3.56%
- Zentalis Pharmaceuticals, Inc. ZNTL 2.13 −4.91%
MacroGenics, Inc. and Zentalis Pharmaceuticals, Inc. are both Biotechnology companies. MacroGenics, Inc. and Zentalis Pharmaceuticals, Inc. are of similar size ($214.7M and $212.1M). Zentalis Pharmaceuticals, Inc. has the higher net margin (0.00% vs −7.97%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Zentalis Pharmaceuticals, Inc. leads on 7 and MacroGenics, Inc. on 5.
Valuation
Profitability
| Metric | MGNX | ZNTL | Biotechnology median |
|---|---|---|---|
| Gross margin | 78.07% | 0.00% | 65.16% |
| Operating margin | (18.73%) | 0.00% | 0.00% |
| Net margin | (7.97%) | 0.00% | 0.00% |
| Free cash flow margin | (35.80%) | 0.00% | 0.00% |
| Return on equity | (32.61%) | (66.75%) | (56.36%) |
| Return on assets | (4.94%) | (49.22%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack